Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "ITU"

2062 News Found

Thailand and GHIT Fund join forces to tackle infectious diseases
News | April 08, 2026

Thailand and GHIT Fund join forces to tackle infectious diseases

The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand


Asia emerges new hotspot for healthcare ransomware, says report
Digitisation | April 08, 2026

Asia emerges new hotspot for healthcare ransomware, says report

Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs


Dabur reports steady domestic growth amid global headwinds in Q4 FY26
News | April 08, 2026

Dabur reports steady domestic growth amid global headwinds in Q4 FY26

The India FMCG business showed a sequential recovery and is expected to post high-single digit growth


Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health
News | April 08, 2026

Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health

TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners


Biocon launches denosumab biosimilars Bosaya and Aukelso in US market
Biopharma | April 08, 2026

Biocon launches denosumab biosimilars Bosaya and Aukelso in US market

Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market


Amgen’s TEPEZZA injection clears Phase 3 trial with high efficacy
Clinical Trials | April 08, 2026

Amgen’s TEPEZZA injection clears Phase 3 trial with high efficacy

The trial also demonstrated significant improvements across multiple secondary endpoints


Aurobindo gets USFDA approval for Dapagliflozin with 180-day exclusivity
Drug Approval | April 08, 2026

Aurobindo gets USFDA approval for Dapagliflozin with 180-day exclusivity

Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size


Aurobindo Pharma wins USFDA approval for generic Xigduo XR
Drug Approval | April 08, 2026

Aurobindo Pharma wins USFDA approval for generic Xigduo XR

Immediate U.S. launch planned for dapagliflozin-metformin ER tablets; addressable market estimated at $514 millionannually


MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases
Biopharma | April 07, 2026

MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases

India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases


SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education
Healthcare | April 06, 2026

SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education

Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings